Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A lot-matched COA is available on this product page and in our COA library before purchase, documenting identity, purity, and full analytical results
This corresponded to an average (SD) GCGR occupancy of 11.2 (14.4) % at a dose of 0.2 mg SAR425899
Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome
The use of GLP-1 agonists was found to be associated with a modest (5%) weight loss
After 5 days at 0.25mg with no adverse effects, the protocol advances to 0.5mg daily for another 57 days
M.ThomsenH.et al (2016)
US$ 26.17
US$ 27.87
US$ 28.67
US$ 22.77
US$ 28.86
US$ 20.72
US$ 22.74
US$ 23.71
US$ 22.45
